MyFinsight
Home
Blog
About
Contact
Download
Download image
Sublocade
$218M
(33.74%↑ Y/Y)
Sublingual And Other
$50M
(-7.41%↓ Y/Y)
Perseris
$5M
(25.00%↑ Y/Y)
US
$272M
(22.52%↑ Y/Y)
Non Us
$45M
(2.27%↑ Y/Y)
Net revenue
$317M
(19.17%↑ Y/Y)
Gross profit
$277M
(25.34%↑ Y/Y)
Cost of sales
$40M
(-9.09%↓ Y/Y)
Operating income
$137M
(107.58%↑ Y/Y)
Interest (income)
$3M
(-25.00%↓ Y/Y)
Total operating
expenses
$139M
(-10.90%↓ Y/Y)
Income before income
taxes
$115M
(94.92%↑ Y/Y)
Loss on debt
extinguishment
-$18M
Interest expense
$7M
(-41.67%↓ Y/Y)
Selling, general and
administrative
$124M
(-6.06%↓ Y/Y)
Research and development
$16M
(-27.27%↓ Y/Y)
Net income
$89M
(89.36%↑ Y/Y)
Income tax expense
$26M
(136.36%↑ Y/Y)
Back
Back
Income Statement
indivior-logo-svg
Indivior Pharmaceuticals, Inc. (INDV)
indivior-logo-svg
source: myfinsight.com
Indivior Pharmaceuticals, Inc. (INDV)